GI
LBRX

GAMMA Investing’s LB Pharmaceuticals LBRX Stock Holding History

GAMMA Investing’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.36K Buy
196
+34
+21% +$999 ﹤0.01% 3381
2026
Q1 		$4K Buy
162
+148
+1,057% +$3.41K ﹤0.01% 3449
2025
Q4 		$312 Buy
+14
New +$245 ﹤0.01% 3961

Other funds holding LBRX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

GAMMA Investing's LBRX Position: Q2 2026 in Review

GAMMA Investing increased its LB Pharmaceuticals (LBRX) stake by 21% in Q2 2026, buying an estimated $999 and bringing the position to 196 shares worth $6.36K. The position accounts for ﹤0.01% of the portfolio, ranked #3381.

GAMMA Investing first reported a position in LBRX in Q4 2025 and has held it in 3 quarters since. 5 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.

  • GAMMA Investing held 196 shares of LB Pharmaceuticals worth $6.36K as of Q2 2026.
  • GAMMA Investing bought 34 LB Pharmaceuticals shares in Q2 2026, an estimated $999.
  • LB Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3381 holding.
  • GAMMA Investing first reported a position in LB Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 5 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.